Toll-like receptor agonist therapy can profoundly augment the antitumor activity of adoptively transferred CD8(+) T cells without host preconditioning (Q36583710)
Jump to navigation
Jump to search
scientific article published on 16 February 2016
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Toll-like receptor agonist therapy can profoundly augment the antitumor activity of adoptively transferred CD8(+) T cells without host preconditioning |
scientific article published on 16 February 2016 |
Statements
1 reference
Toll-like receptor agonist therapy can profoundly augment the antitumor activity of adoptively transferred CD8(+) T cells without host preconditioning (English)
1 reference
Michelle H Nelson
Marshall A Diven
Caroline W Fugle
Andrew D M Kaiser
Claudia Wrzesinski
Bei Liu
Chrystal M Paulos
16 February 2016
1 reference